~~<i id='5C2D9F2FE5'><strike id='5C2D9F2FE5'><tt id='5C2D9F2FE5'><pre id='5C2D9F2FE5'></pre></tt></strike></i>~~

Home» explore» knowledge

knowledge

author：hotspot 2025-09-30 07:37:18 Page View：8

You’re reading the web edition of STAT’s Health Tech newsletter, our guide to how technology is transforming the life sciences. Sign up to get it delivered in your inbox every Tuesday and Thursday.

Diabetes: Better shows data on app’s benefit with GLP-1s

Better Therapeutics announced top-line data suggesting that its prescription app for diabetes treatment, AspyreRx, can boost the impact of GLP-1 diabetes treatments. According to the release, a subgroup analysis of 160 participants in its pivotal trial on GLP-1 treatment found that the behavior modification app produced statistically significant reductions in A1C compared to a control group.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Readout Newsletter: Illumina, CRISPR, Regeneron
Next article： New air purifier tech could be key to improving indoor air quality

explore

New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum

CMSAdministratorChiquitaBrooks-LaSureChipSomodevilla/GettyImagesWASHINGTON— EliLilly’slatestanti-amy

6 solutions to address cancer drug shortages and others

GeorgeFrey/GettyImagesWASHINGTON—RepublicansandDemocratsalikewanttostopdrugshortagesfromhappening.Th

Guidelines to prevent youth baseball injuries need more muscle

Apitcheratthe2018LittleLeagueWorldSeries.RobCarr/GettyImages“Weallknowthatweareinthemiddleofanepidem

Mirador, a new biotech startup, launches with $400 million

AdobeWhathappensafteryoucloseanearly$11billionacquisition?Well,forPrometheusTherapeutics’formerCEOMa